https://www.empr.com/home/mpr-first-report/id-week-2022/ridinilazole-reduces-c-difficile-infection-recurrence-more-effectively-than-vancomycin/
0
0
10/24/22 at 1:00pm
Organization
Empr.com
Author
Steve Duffy
32 words
0
Comments
Treatment with ridinilazone was found to significantly decrease the rate of recurrent Clostridioides difficile infection (CDI) compared with vancomycin.
You are the first to view
Create an account
or login to join the discussion